Jennifer Shepphird, PhD | Authors


Cirmtuzumab Blocks Ovarian Cancer Metastasis in Preclinical Study

November 18, 2014

The monoclonal antibody cirmtuzumab, currently in clinical trials to treat CLL, targets ROR1 on the surface of cancerous B cells, and the agent may have a wider reach in the treatment of ovarian and other cancers.

HIV Has Role in CAR-T Therapy

November 13, 2014

Recent news stories profiling a cancer patient whose last hope rests on treatment by injections of the virus that causes AIDS may have created some misconceptions regarding a new cancer immunotherapy.